1. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
   Jesus I. Luna et al, 2017, Expert Opinion on Biological Therapy CrossRef
2. Fractional uptake of circulating tumor cells into liver‑lung compartments during curative resection of periampullary cancer
   Caroline Vilhav et al, 2018, Oncology Letters CrossRef
3. Downregulation of MICA/B tumor surface expressions and augmented soluble MICA serum levels correlate with disease stage in breast cancer
   Jeevitaa Kshersagar et al, 2023, Breast Disease CrossRef
4. MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma
   Liang Fang et al, 2014, Journal of Experimental & Clinical Cancer Research CrossRef
5. Influence of Innate Immunity on Cancer Cell Stemness
   Anna Pastò et al, 2020, International Journal of Molecular Sciences CrossRef
6. Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma
   Marie-Claire Rittmann et al, 2021, Scientific Reports CrossRef
7. High expression of diffuse panbronchiolitis critical region 1 gene promotes cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma
   Jiayi Yan et al, 2018, Biochemical and Biophysical Research Communications CrossRef
8. Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review
   Jonas R.M. Van Audenaerde et al, 2018, Pharmacology & Therapeutics CrossRef
9. The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
   Ge Tan et al, 2023, Biology CrossRef
10. Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study
    Guillaume Onyeaghala et al, 2019, PLOS ONE CrossRef
11. Stress-induced MICA and MICB molecules in oncology
    S. A. Yurevna et al, 2022, Medical Immunology (Russia) CrossRef
12. Effect of Surgery on Pancreatic Tumor-Dependent Lymphocyte Asset
    Francesco Iannone et al, 2015, Pancreas CrossRef
13. Transcriptome analysis of the gill of Takifugu rubripes using Illumina sequencing for discovery of SNPs
    Jun Cui et al, 2014, Comparative Biochemistry and Physiology Part D: Genomics and Proteomics CrossRef
14. DNT cell inhibits the growth of pancreatic carcinoma via abnormal expressions of NKG2D and MICA in vivo
    Hong Xu et al, 2016, Biochemical and Biophysical Research Communications CrossRef
15. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer
    Marcelo J. Sakiyama et al, 2019, Experimental and Molecular Pathology CrossRef
16. Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?
    Fatemeh Vahidian et al, 2019, Immunology Letters CrossRef
17. Process of hepatic metastasis from pancreatic cancer: biology with clinical significance
    Haojun Shi et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
18. Association of MICA gene Exon-5 polymorphism in oral submucous fibrosis
    Sangeetha Jeevankumar et al, 2023, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology CrossRef
19. Leveraging NKG2D Ligands in Immuno-Oncology
    Mercedes Beatriz Fuertes et al, 2021, Frontiers in Immunology CrossRef
20. The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
    Florencia Secchiari et al, 2022, OncoImmunology CrossRef
21. Soluble MICA in Biofluids as Biomarker in Tracing Oral Malignant Growth Which Relates with Disease Stage
    Jeevitaa Kshersagar et al, 2022, Annals of Cancer Research and Therapy CrossRef
22. Models to Study NK Cell Biology and Possible Clinical Application
    Anthony E. Zamora et al, 2015, Current Protocols in Immunology CrossRef
23. Soluble MICA is elevated in pancreatic cancer: Results from a population based case‐control study
    Guillaume Onyeaghala et al, 2017, Molecular Carcinogenesis CrossRef